Revance Therapeutic (RVNC) PT Lowered to $11 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts RVNC Hot Sheet
Price: $3.65 --0%
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 18 | New: 11
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 18 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $11.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- Jefferies Upgrades U.S. Bancorp (USB) to Buy
- Morgan Stanley Downgrades J.B. Hunt Transport Services (JBHT) to Underweight
- Jefferies Downgrades Huntington Bancshares (HBAN) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
